Advertisement

Topics

Wider Sampling Of Tumor Tissues May Guide Drug Choice, Improve Outcomes

04:55 EST 27 Nov 2017 | Pharmaceutical Processing

Many current approaches to genome-guided therapy, often referred to as "precision medicine," have produced imprecise results. This is particularly the case for gastric and esophageal adenocarcinoma (GEA), which are common cancers.
Contributed Author: 
University of Chicago Medical Center

Original Article: Wider Sampling Of Tumor Tissues May Guide Drug Choice, Improve Outcomes

NEXT ARTICLE

More From BioPortfolio on "Wider Sampling Of Tumor Tissues May Guide Drug Choice, Improve Outcomes"

Advertisement
Quick Search
Advertisement
Advertisement